Despite inflationary pressures from high commodity prices, GlaxoSmithKline Consumer Healthcare benefited from a cost engineering programme which saw it post an 18 per cent rise in net profit at Rs.355 crore (Rs.299.80 crore) for the year ended December 2011.
The directors have recommended a dividend of Rs.35 per share of Rs.10 for the year.
Net sales were up 16 per cent at Rs.2,686 crore. The gross profit was up 20 per cent at Rs.540 crore.
For the fourth quarter ended December 2011, the company reported a net profit of Rs.59 crore (Rs.53.37 crore) on 19 per cent higher sales of Rs.602 crore (Rs.508 crore).
Zubair Ahmed, Managing Director, said, “It is gratifying to note that quarter after quarter GSK is able to record strong top line growth by leveraging science and innovation.”
Adani Power, part of Adani group reported a loss of Rs.358 crore in the third quarter ended December 31, 2011, against a profit of Rs.109 crore in the corresponding quarter in the previous year. Net sales shot up to Rs. 1,059 crore against Rs.503 crore.
For the nine-month period ended December 31, 2011, the company clocked a loss of Rs. 4 crore as compared to a profit of Rs. 349 crore in the year-ago period. Net sales were higher at Rs. 2,951 crore against Rs.1,251 crore.
Rane Holdings has reported a 14 per cent rise in its sales and operating income at Rs. 463.41 crore (consolidated) in the third quarter ended December 31, 2011, against Rs.407.65 crore for the same quarter in the previous year. The profit after tax was up 56 per cent at Rs. 20.95 crore against Rs.13.39 crore in the year-ago period. L. Lakshman, Executive Chairman, observed that group companies had posted a healthy growth over the same quarter in the previous year although there was significant reduction in demand from the passenger car segment.
TAKE Solutions has increased its total income to Rs. 22.07 crore in the three months ended December 31, 2011, from Rs. 16.79 crore in the same period in the previous year. The net profit after tax has risen by 59 per cent to Rs. 12.30 crore from Rs. 7.74 crore.
Keywords: GSK Consumer Health